Browsing by Author Tak, WY

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 4 of 4
TitleAuthor(s)Issue Date
 
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Journal:The Lancet Oncology
Bruix, JTakayama, TMazzaferro, VChau, GYYang, JKudo, MCai, JPoon, RTPHan, KHTak, WYLee, HCSong, TRoayaie, SBolondi, LLee, KSMakuuchi, MSouza, FBerre, MAMeinhardt, GLlovet, JM
2015
 
Phase 3, randomized, double-blind, dummy-controlled, trial of radiofrequency ablation (RFA) + lyso-thermosensitive liposomal doxorubicin (LTLD, Thermodox), for hepatocellular carcinoma (HCC) lesions 3-7 cm
Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2013
Tak, WYLin, SMWang, YZheng, JIzzo, FPark, SYChen, MHWong, SNXu, RPeng, CYChiou, YYHuang, GTLee, JYSherman, MAbdullah, BJJLee, JSWang, JHBorys, NPoon, RTPLencioni, R
-
 
A randomized, double-blind, multicenter phase 3 study of brivanib versus placebo as adjuvant therapy to trans-arterial chemoembolization in patients with unresectable hepatocellular carcinoma: initial results
Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2013
Kudo, MFinn, RPoon, RTPBlanc, JFHan, GYan, LYang, JLu, LTak, WYXU, XLee, JHLin, SMWu, CTanwandee, TShao, GWalters, LDela Cruz, CPoulart, VWang, JH
2013
 
Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B
Proceeding/Conference:Hepatology
Chan, HLYLim, YSSeto, WKWAgarwal, KBrunetto, MRJanssen, HLACaruntu, FStepanova, TTsang, OYatsuhashi, HTak, WYChen, CYCelen, MSun, VFlaherty, JFLin, LCathcart, AGaggar, APan, CQShalimarButi, M
2018
Showing results 1 to 4 of 4